Gilead Sciences, Inc.

€75.39 0.20%
XETRA: GIS.DE
Market Cap.: 93.9 B L
P/E: 103.27 x34.54
EPS: 0.73 x 4.94
Earnings Call
1 month, 2 weeks from now
Dividend Waiting Time
n.A.
Latest Dividends History
Yield: 3.77%
Payout: 67.24%
Volume Level
μ 1,783
1,176 Moderate Low
Performance Ranks (Intraday)
United States:

1408th

out of

2160

Healthcare:

416th

out of

792

Drug Manufacturers—General:

30th

out of

62

Peer Group:

2nd

out of

4

About

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, …